Log in
Enquire now
‌

ReproNovo

Developer of treatments for reproductive medicine and women’s health.

OverviewStructured DataIssuesContributors

Contents

repronovo.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Fertility
Fertility
Pharmaceutical industry
Pharmaceutical industry
Health technology
Health technology
Biotechnology
Biotechnology
CEO
‌
Jean Marie Duvall
Founder
‌
Jean Marie Duvall
‌
BingMei Hao
Number of Employees (Ranges)
11 – 50
Email Address
info@repronovo.com
Investors
Ysios Capital
Ysios Capital
Axa Investment Managers
Axa Investment Managers
Jeito Capital
Jeito Capital
ALSA Ventures
ALSA Ventures
M Ventures
M Ventures
Founded Date
2020
Total Funding Amount (USD)
65,000,000
Latest Funding Round Date
May 21, 2025
CFO
‌
BingMei Hao
Latest Funding Type
Series A
Series A
Country
Switzerland
Switzerland
Headquarters
Lausanne
Lausanne

Other attributes

Latest Funding Round Amount (USD)
65,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like ReproNovo

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.